You are here » Home » Companies » Company Overview » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE LIVE 15:55 | 23 Oct 598.65 -10.85
(-1.78%)
OPEN

610.00

HIGH

610.00

LOW

595.10

NSE 15:55 | 23 Oct 598.40 -10.15
(-1.67%)
OPEN

609.65

HIGH

610.15

LOW

594.65

OPEN 610.00
PREVIOUS CLOSE 609.50
VOLUME 58199
52-Week high 993.00
52-Week low 567.95
P/E 8.37
Mkt Cap.(Rs cr) 16,894
Buy Price 598.65
Buy Qty 409.00
Sell Price 0.00
Sell Qty 0.00
OPEN 610.00
CLOSE 609.50
VOLUME 58199
52-Week high 993.00
52-Week low 567.95
P/E 8.37
Mkt Cap.(Rs cr) 16,894
Buy Price 598.65
Buy Qty 409.00
Sell Price 0.00
Sell Qty 0.00

Glenmark Pharmaceuticals Ltd. (GLENMARK) - Company Information

Glenmark Pharmaceuticals Ltd

COMPANY INFORMATION
Chairman & Managing Director : Glenn Saldanha
Independent Director : Julio F Ribeiro
Independent Director : Sridhar Gorthi
Director (Corporate Affairs) : Cheryl Pinto
Independent Director : D R Mehta
Director : B E Saldanha
Non Executive Director : Rajesh Desai
Independent Director : Brian W Tempest
Independent Director : Bernard Munos
Independent Director : Milind Sarwate
Company Secretary : Harish Kuber
Executive Director : Murali Neelakantan
AUDITOR : Walker Chandiok & Co LLP
IND NAME : Pharmaceuticals - Indian - Bulk Drugs & Formln
HOUSE NAME : Indian Private
Registered office
B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road,Mumbai,Maharashtra-400026
Ph : 91-22-40189999
WEBSITE : http://www.glenmarkpharma.com
E-mail : complianceofficer@glenmarkpharma.com